0001140361-24-037709.txt : 20240816 0001140361-24-037709.hdr.sgml : 20240816 20240816210134 ACCESSION NUMBER: 0001140361-24-037709 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240814 FILED AS OF DATE: 20240816 DATE AS OF CHANGE: 20240816 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ma Songjiang CENTRAL INDEX KEY: 0001985547 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51173 FILM NUMBER: 241218070 MAIL ADDRESS: STREET 1: 12730 HIGH BLUFF DRIVE STREET 2: SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GYRE THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001124105 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 562020050 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12770 HIGH BLUFF DRIVE, SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (619) 949-3681 MAIL ADDRESS: STREET 1: 12770 HIGH BLUFF DRIVE, SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST BIOSCIENCES, INC. DATE OF NAME CHANGE: 20150820 FORMER COMPANY: FORMER CONFORMED NAME: TARGACEPT INC DATE OF NAME CHANGE: 20000919 4 1 form4.xml FORM 4 X0508 4 2024-08-14 0001124105 GYRE THERAPEUTICS, INC. GYRE 0001985547 Ma Songjiang C/O GYRE THERAPEUTICS, INC. 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130 true true President false Stock Option (Right to Buy) 9.98 2024-08-14 4 A 0 26000 0 A 2034-08-14 Common Stock 26000 26000 D This option represents a right to purchase a total of 26,000 shares of the Issuer's common stock, which will vest in 12 equal monthly installments through August 14, 2025, subject to the Reporting Person's continued service to the Issuer through each vesting date. /s/ Ruoyu Chen, as attorney-in-fact for Songjiang Ma 2024-08-16